A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/11/2006	EP1709155A2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
10/11/2006	EP1709084A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins
10/11/2006	EP1709066A1 Inclusion complexes of perindopril
10/11/2006	EP1709063A2 Glycosylated steroid derivatives with anti-migratory activity
10/11/2006	EP1709061A1 Di-steroidal prodrugs of ethinyl estradiol
10/11/2006	EP1709060A1 Di-steroidal prodrugs of estradiol
10/11/2006	EP1709056A1 Phosphoramidate derivatives
10/11/2006	EP1709053A1 Stable salts of olanzapine
10/11/2006	EP1709052A1 Derivatives of 1,4-diazabicyclo 3.2.1octanecarboxamide, preparation method thereof and use of same in therapeutics
10/11/2006	EP1709051A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
10/11/2006	EP1709049A1 Bicyclic imidazole compounds, the production thereof and their use as medicaments
10/11/2006	EP1709047A2 Azabenzofuran substituted thioureas as inhibitors of viral replication
10/11/2006	EP1709046A1 P38 kinase inhibitors
10/11/2006	EP1709045A1 Naphthyridine derivatives and their use as modulators of muscarinic receptors
10/11/2006	EP1709044A2 Oxazolidinone-quinolone hybrid antibiotics
10/11/2006	EP1709043A1 Pyrrolopyridine-substituted benzol derivatives for treating cardiovascular diseases
10/11/2006	EP1709042A1 Spirocyclic quinuclidinic ether derivatives
10/11/2006	EP1709041A1 Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
10/11/2006	EP1709037A2 Hiv protease inhibiting sulfonamides
10/11/2006	EP1709036A1 Thiazole derivatives as a2b antagonists
10/11/2006	EP1709035A1 1 , 3 - dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes
10/11/2006	EP1709033A1 New polymorphic forms of ondansetron, processes for preparing them, pharmaceutical compositions containing them and their use as antiemetics
10/11/2006	EP1709031A1 Chrysogenazine obtained from fungus penicillium chrysogenum having antibacterial activity
10/11/2006	EP1709028A1 Fused heteroaryl derivatives and their use as p38 kinase inhibitors
10/11/2006	EP1709027A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
10/11/2006	EP1709022A1 Selective estrogen receptor modulators
10/11/2006	EP1709021A1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
10/11/2006	EP1709020A2 Processes for preparing novel methylene blue derivative
10/11/2006	EP1709019A2 Thiazole derivatives and use thereof
10/11/2006	EP1709018A1 Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
10/11/2006	EP1709017A1 Urea derivatives
10/11/2006	EP1709015A1 Organic compounds
10/11/2006	EP1709014A1 Antidiabetic oxazolidinediones and thiazolidinediones
10/11/2006	EP1709012A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose)polymerase inhibitors
10/11/2006	EP1709009A1 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
10/11/2006	EP1709007A1 N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors
10/11/2006	EP1709006A1 Benzimidazole derivatives
10/11/2006	EP1709005A1 High purity butoconazole nitrate with specified particle size and a process for preparation thereof
10/11/2006	EP1709004A2 Pyrrole and pyrazole daao inhibitors
10/11/2006	EP1709003A1 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
10/11/2006	EP1709002A2 Montelukast sodium polymorphs
10/11/2006	EP1709000A1 Piperidine derivatives as gcs inhibitors
10/11/2006	EP1708999A1 Bronchorelaxing compounds
10/11/2006	EP1708998A1 Indol-alanine derivatives as selective s1p4-agonists
10/11/2006	EP1708996A1 Fused heteroyral derivatives for use as p38 kinase inhibitors
10/11/2006	EP1708994A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/11/2006	EP1708993A2 Novel surfactants and applications thereof
10/11/2006	EP1708990A1 Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity
10/11/2006	EP1708988A1 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
10/11/2006	EP1708987A1 L-(-)-moprolol l-(+)-tartrate
10/11/2006	EP1708790A1 Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
10/11/2006	EP1708763A1 Methods, compositions, and devices for embolizing body lumens
10/11/2006	EP1708754A2 COMBINATIONS OF SEROTONIN REUPTAKE INHIBITORS AND IMIDAZOLINE-I sb 2 /sb -AGONISTS
10/11/2006	EP1708742A2 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
10/11/2006	EP1708739A1 Neuroprotective complex for treatment of cerebral ischemia and injury
10/11/2006	EP1708729A1 Composition comprising an aqueous extract of red vine leaves and a diuretic for the treatment of chronic venous insufficiences
10/11/2006	EP1708728A1 Composition comprising an aqueous extract of red vine leaves and a antithrombotic agent for the treatment of chronic venous insufficiences
10/11/2006	EP1708727A1 Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent for the treatment of chronic venous insufficiences
10/11/2006	EP1708725A1 Therapeutical composition for the treatment of dermatosis comprising an extract of calendula officinalis and hypericum perforatum
10/11/2006	EP1708724A1 Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
10/11/2006	EP1708722A1 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
10/11/2006	EP1708721A1 Myocardial perfusion imaging using adenosine receptor agonists
10/11/2006	EP1708720A1 Core 2 glcnac-t inhibitors
10/11/2006	EP1708719A2 Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use
10/11/2006	EP1708718A1 Triazole derivatives which inhibit vasopressin antagonistic activity
10/11/2006	EP1708717A2 Treatment of allergic rhinitis and asthma
10/11/2006	EP1708716A2 Oral dieting composition comprising conjugated linoleic acid and caffeine
10/11/2006	EP1708715A1 Use of substituted pteridines for the treatment of diseases of the respiratory tract
10/11/2006	EP1708714A1 Use of substituted pyrimido pyrimido 5,4-d¨pyrimidines in the treatment of diseases of the respiratory tract
10/11/2006	EP1708713A1 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1h-quinazolin-2-one derivatives and the respective 1h-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(d)(1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-ht) for the treatment of diseases of the central nervous system
10/11/2006	EP1708712A1 Treatment of malignant gliomas with tgf-beta inhibitors
10/11/2006	EP1708711A1 Compositions useful especially for treatment or prevention of metabolic syndrome
10/11/2006	EP1708710A1 Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
10/11/2006	EP1708709A1 METHODS OF TREATING ACUTE INFLAMMATION IN ANIMALS WITH p38 MAP KINASE INHIBITORS
10/11/2006	EP1708708A1 Montelukast free acid polymorphs
10/11/2006	EP1708707A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
10/11/2006	EP1708706A1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
10/11/2006	EP1708705A1 Pharmaceutical composition for promoting angiogenesis
10/11/2006	EP1708704A2 4-aryl piperidines
10/11/2006	EP1708703A2 Chemokine receptor binding compounds
10/11/2006	EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists
10/11/2006	EP1708701A1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
10/11/2006	EP1708700A1 Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
10/11/2006	EP1708699A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- k .b activity and use thereof
10/11/2006	EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006	EP1708697A2 Chemical compounds
10/11/2006	EP1708696A1 Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/11/2006	EP1708695A1 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
10/11/2006	EP1708694A2 Compositions and methods for treating contracture
10/11/2006	EP1708693A1 Pharmaceutical compositions containing paltinum complexes with secondary xanthates and therapeutic uses thereof
10/11/2006	EP1708692A1 Dichloroacetate in combination with an inotrope for cardioprotection
10/11/2006	EP1708691A1 Combination of organic compounds
10/11/2006	EP1708690A2 Treatment of phenylketonurias with bh4
10/11/2006	EP1708689A2 Compositions for treating or preventing obesity and insulin resistance disorders
10/11/2006	EP1708686A2 Generally linear effervescent oral fentanyl dosage form and methods of administering
10/11/2006	EP1708685A2 Effervescent oral opiate dosage forms and methods of administering opiates
10/11/2006	EP1708684A2 Drug coating providing high drug loading and methods for providing the same
10/11/2006	EP1708681A1 Cefdinir oral suspension
10/11/2006	EP1708680A2 Mitratapide oral solution
10/11/2006	EP1708679A2 Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin

1 ... 4055 4056 4057 4058 4059 4060 4061 4062 4063 4064 4065 4066 4067 4068 4069 4070 4071 4072 4073 4074 4075 ... 7860